The Technical Analyst
Prestige Consumer [PBH]
Exchange: NYSE Sector: Healthcare Industry: Medical Distribution
Prestige Consumer Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.34% $70.09
America/New_York / 9 mai 2024 @ 10:32
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 482.71 mill |
| EPS: | -1.650 |
| P/E: | -42.48 |
| Earnings Date: | Aug 02, 2023 |
| SharesOutstanding: | 49.69 mill |
| Avg Daily Volume: | 0.227 mill |
| RATING 2024-05-08 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -42.48 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -1.65x |
| Company: PE -42.48 | industry: PE 25.81 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$186.78 (166.51%) $116.70 |
| Date: 2024-05-09 |
| Expected Trading Range (DAY) |
|---|
|
$ 68.83 - 71.35 ( +/- 1.80%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-05-06 | Fritz Mary Beth | Buy | 3 456 | Common Stock, par value $0.01 per share |
| 2024-05-06 | Fritz Mary Beth | Sell | 1 597 | Common Stock, par value $0.01 per share |
| 2024-05-06 | Lombardi Ronald M. | Sell | 41 356 | Common Stock, par value $0.01 per share |
| 2024-05-06 | Lombardi Ronald M. | Buy | 85 533 | Common Stock, par value $0.01 per share |
| 2024-05-06 | Zerillo Jeffrey | Buy | 3 894 | Common Stock, par value $0.01 per share |
| INSIDER POWER |
|---|
| -12.41 |
| Last 99 transactions |
| Buy: 300 595 | Sell: 405 248 |
Forecast:
12:11 - $69.99
Live Trading Signals (every 1 min)
Forecast
1: 10:41 - $70.07
Forecast 2: 11:31 - $70.07
Forecast 3: 12:11 - $69.99
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $70.09 (0.34% ) |
| Volume | 0.0068 mill |
| Avg. Vol. | 0.227 mill |
| % of Avg. Vol | 3.00 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PBH
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Latest Press Releases
2024-04-25 08:30:00 - Press Release
Prestige Consumer Healthcare Inc. To Release Fiscal 2024 Fourth Quarter And Year-end Earnings Results
Tarrytown, n.y., april 25, 2024 (globe newswire) -- prestige consumer healthcare inc. (nyse:pbh) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on tuesday, may 14, 2024 after the market close. the company will host a conference call to discuss the results the following morning, may 15th, at 8:30 a.m. et.
2024-04-03 11:57:00 - Press Release
Dramamine® Celebrates Its 75th Anniversary By Reviving An Unexpected Partner: The Barf Bag
The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bags the nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bags
2024-02-08 06:00:00 - Press Release
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
Tarrytown, n.y., feb. 08, 2024 (globe newswire) -- prestige consumer healthcare inc. (nyse:pbh) today reported financial results for its third quarter and first nine months ended december 31, 2023.
2024-02-02 09:00:00 - Press Release
Insight Pharmaceuticals Issues Voluntary Nationwide Recall Of Ting® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due To The Presence Of Benzene
Tarrytown, n.y., feb. 02, 2024 (globe newswire) -- insight pharmaceuticals, a prestige consumer healthcare inc. company (“insight”), is voluntarily recalling two lots of ting® 1% tolnaftate athlete's foot spray antifungal spray liquid to the consumer level. a recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. while benzene is not an ingredient in any ting® antifungal spray products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. importantly, no other lots of ting® 1% tolnaftate athlete's foot spray antifungal spray liquid (either before or after these batch codes) and no other ting® antifungal spray liquid products are in the scope of this recall and may continue to be used by consumers safely and as intended.
2024-01-10 17:00:00 - Press Release
Prestige Consumer Healthcare Inc. To Release Fiscal 2024 Third Quarter Earnings Results
Tarrytown, n.y., jan. 10, 2024 (globe newswire) -- prestige consumer healthcare inc. (nyse:pbh) today announced that it will issue its fiscal 2024 third quarter earnings release on thursday, february 8, 2024 before the opening of the market. the company will host a conference call to discuss the results that same morning at 8:30 a.m. et.
Latest News
2024-05-09 10:16:24 - Zacks Investment Research
Unveiling Prestige Consumer Healthcare (PBH) Q4 Outlook: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Prestige Consumer Healthcare (PBH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
2024-04-30 12:46:18 - Zacks Investment Research
PBH vs. ABT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
2024-04-19 08:45:26 - Zacks Investment Research
Here's Why You Should Retain Prestige Consumer (PBH) Stock Now
The robust strength of Prestige Consumer's (PBH) diversified portfolio bodes well for investors.
2024-04-08 10:41:10 - Zacks Investment Research
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2024-04-02 10:11:06 - Zacks Investment Research
Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
Prestige Consumer (PBH) develops long-term partnerships across its diverse retail footprint and invests heavily in the e-commerce channel.
2024-03-25 10:56:19 - Zacks Investment Research
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
2024-03-21 11:46:51 - Zacks Investment Research
Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
2024-03-05 13:56:04 - Zacks Investment Research
Reasons to Retain Prestige Consumer (PBH) Stock for Now
Investors are optimistic about Prestige Consumer (PBH) on increasing gain in market share for its wide array of brands.
2024-02-29 10:56:10 - Zacks Investment Research
Why Prestige Consumer Healthcare (PBH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2024-02-09 09:11:06 - Zacks Investment Research
Prestige Consumer (PBH) Q3 Earnings Top, Gross Margin Expands
Prestige Consumer's (PBH) third-quarter fiscal 2024 results reflect the power of a well-positioned and diversified portfolio.